
Ramey Elsarrag MD MS
Hospital Medicine/Hospitalist, Hematology/Oncology
Physician
Join to view full profile
1 Medical Center BoulevardWinston-Salem, NC 27103
Dr. Elsarrag is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology, 2023 - 2026
University of Virginia Medical CenterResidency, Internal Medicine, 2020 - 2023
University of Virginia School of MedicineClass of 2020
Certifications & Licensure
NC State Medical License 2023 - 2026
VA State Medical License 2023 - 2026
American Board of Internal Medicine Internal Medicine
National Board of Physicians and Surgeons Internal Medicine
Publications & Presentations
PubMed
- Impact of diagnosis-to-treatment interval on the outcome of patients with acute myeloid leukemia.Samah Nassereddine, Yuan Feng, Jordan Selep, Firas El Chaer, Leah Wells
Annals of Hematology. 2026-05-09 - 4 citationsGilteritinib: An FMS-like tyrosine kinase 3/AXL tyrosine kinase inhibitor for the treatment of relapsed or refractory acute myeloid leukemia patients.Daniel R Reed, Jeremy M Sen, Eric J Pierce, Ramey Z Elsarrag, Michael K Keng
Journal of Oncology Pharmacy Practice. 2020-04-26 - 12 citationsEnasidenib in acute myeloid leukemia: clinical development and perspectives on treatment.Daniel R Reed, Ramey Z Elsarrag, Amy Morris, Michael K Keng
Cancer Management and Research. 2019-08-30
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: